TUSAMITAMAB
UNII L5ZKA40LJR

Substance Identification & Data

This profile provides standardized clinical and technical data for Tusamitamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) L5ZKA40LJR.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2349294-95-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

L5ZKA40LJR

CAS Registry Number

2349294-95-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TUSAMITAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C175867

National Cancer Institute reference terminology for clinical and research data.

INN ID

11467

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-67

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tusamitamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TUSAMITAMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1 (DE-450-LYSINE), ANTI-(HUMAN CARCINOEMBRYONIC ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL SAR408377 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SAR408377 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CARCINOEMBRYONIC ANTIGEN, MECONIUM ANTIGEN 100, ANTIGEN_CD66E)) HUMANIZED MOUSE MONOCLONAL ANTIBODY; .GAMMA.1 HEAVY CHAIN (1-449) (VH(MUS MUSCULUS IGHV5-12-1*01 (87%)-(IGHD)-IGHJ3*01 (93%)/HOMO SAPIENS IGHV3-23*01 (77%) IGHJ4*01 (93%)) (8.8.13) (1-120)-HOMO SAPIENS IGHG1*01 (CH3(K107>DEL(450))) (121-449) (223-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (V-KAPPA (MUS MUSCULUS IGKV12-44*01 (87%)-IGKJ4*01/HOMO SAPIENS IGKV1-39*01 (82%)-IGKJ2*02 (91%))(6.3.9) (1'-107') HOMO SAPIENS IGKC*01 (108'-214')), DIMER (229-229'':232-232'')-BISDISULFIDE, PRODUCED IN CHO CELL, GLYCOFORM ALFA

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CEACAM5 (CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5, CEA, CD66E)), MONOCLONAL ANTIBODY

TUSAMITAMAB [INN]

TUSAMITAMAB [USAN]